Home
About
Overview
Management Team
Board of Directors
Technology
Overview
Posters
Pipeline
Overview
MT-3724
MT-5111
TAK-169
Clinical Trials
Overview
MT-3724 With Lenalidomide for Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Active, not recruiting
MT-3724 for Relapsed or Refractory DLBCL
Active, not recruiting
MT-3724 With Gemcitabine and Oxaliplatin for Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Active, not recruiting
MT-5111 in HER2-positive Solid Tumors
Recruiting
TAK-169 for Relapsed or Refractory Multiple Myeloma (RRMM)
Recruiting
News & Media
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Email Alerts
Contact
Careers
Press Releases
News & Media
News & Media
Press Releases
Presentations
Events
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
2013
2011
2010
Category
All Releases
Financial Releases
Molecular Templates to Present at the AACR 101st Annual Meeting
Apr 13, 2010 10:39am EDT
Prev
1
2
3
4
5
6
7
8
9
10
